- Report
- April 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 189 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 194 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- December 2024
United States, Europe, ... United States, Europe, Global, Japan
From €16156EUR$18,500USD£14,035GBP
- Report
- December 2024
Mexico, Canada, North America Mexico, Canada, North America
From €8296EUR$9,500USD£7,207GBP
- Report
- December 2024
United States
From €2183EUR$2,500USD£1,897GBP
- Report
- October 2024
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 173 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- June 2025
- 400 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- October 2023
- 250 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- March 2024
- 95 Pages
From €3013EUR$3,450USD£2,617GBP
- Report
- March 2024
- 113 Pages
Asia Pacific
From €3013EUR$3,450USD£2,617GBP
- Report
- December 2021
- 188 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- August 2022
- 119 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- July 2024
- 157 Pages
Global
From €3155EUR$3,613USD£2,741GBP
€3712EUR$4,250USD£3,224GBP
- Report
- February 2024
India
From €2183EUR$2,500USD£1,897GBP

The Hemostasis Analyzer market is a segment of the Medical Devices industry that focuses on the diagnosis and treatment of hemostatic disorders. Hemostasis Analyzers are used to measure the activity of clotting factors, platelet count, and other parameters related to hemostasis. These devices are used to diagnose and monitor a variety of hemostatic disorders, such as hemophilia, thrombocytopenia, and von Willebrand disease. Hemostasis Analyzers are also used to monitor the effectiveness of anticoagulant therapy.
The Hemostasis Analyzer market is expected to grow due to the increasing prevalence of hemostatic disorders, technological advancements, and the rising demand for point-of-care testing. The market is also driven by the increasing demand for automated hemostasis analyzers and the growing awareness of hemostatic disorders.
Some of the major companies in the Hemostasis Analyzer market include Siemens Healthineers, Sysmex Corporation, Roche Diagnostics, Abbott Laboratories, and Helena Laboratories. Show Less Read more